Enteropathy-associated T-cell lymphoma screening
|
Enteropathy-associated T-cell lymphoma Microchapters |
|
Differentiating Enteropathy-associated T-cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Enteropathy-associated T-cell lymphoma screening On the Web |
|
American Roentgen Ray Society Images of Enteropathy-associated T-cell lymphoma screening |
|
Enteropathy-associated T-cell lymphoma screening in the news |
|
Risk calculators and risk factors for Enteropathy-associated T-cell lymphoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Enteropathy-associated T cell lymphoma is a very rare but aggressive disease, an extranodal form of non-Hodgkin lymphoma which has two subtypes, type I is associated with celiac disease and more common in the western population, type II is more common in Asian countries.[1]
Screening
- There is insufficient evidence to recommend routine screening for enteropathy-associated T-cell lymphoma.
References
- ↑ Kumar, A.; Burger, I. A.; Zhang, Z.; Drill, E. N.; Migliacci, J. C.; Ng, A.; LaCasce, A.; Wall, D.; Witzig, T. E.; Ristow, K.; Yahalom, J.; Moskowitz, C. H.; Zelenetz, A. D. (2016). "Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: prognostic significance of measurements in the coronal and transverse planes". Haematologica. 101 (10): 1237–1243. doi:10.3324/haematol.2016.141846. ISSN 0390-6078.